Q4 & FY 26 Earnings Conference Call Transcript
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jupiter Life Line Hospitals reported FY26 total income of INR1,499.8 crore (up 15.2% YoY) with EBITDA of INR343.3 crore (22.9% margin) and PAT of INR194.2 crore. Q4 revenue was INR387.8 crore with 23% EBITDA margin. The newly commissioned Dombivli hospital (opened February 2026, 2 months ahead of schedule) is in early ramp-up with insurance empanelment expected in 6-12 months and EBITDA breakeven targeted in 2 years (monthly burn of INR2-3 crore). The expansion pipeline includes Dombivli (500 beds), Pune South (CY28), Mira Road (regulatory stage), and a 400-bed BKC facility. Management confirmed capex for ~1,700 beds at ~INR1.5 crore per bed, funded by internal accruals and debt capped at 3x EBITDA. Thane occupancy is ~75%, Pune ~65%, and Indore ~45-50%.
Jupiter delivered strong full-year growth with margin expansion driven by ARPOB improvement (+11.7% to INR67,700) and better case mix. The expansion roadmap to ~3,000 beds is fully funded through internal accruals, keeping balance sheet risk manageable despite significant capex deployment.